TAM
JAZZ icon

Tealwood Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Tealwood Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-18,273
Closed -$1.82M – 93
2020
Q1 		$1.82M Sell
18,273
-963
-5% -$125K 1.03% 54
2019
Q4 		$2.87M Sell
19,236
-658
-3% -$89.5K 1.2% 37
2019
Q3 		$2.55M Sell
19,894
-11,430
-36% -$1.53M 1.1% 46
2019
Q2 		$4.47M Buy
31,324
+173
+0.6% +$23.2K 1.82% 3
2019
Q1 		$4.45M Sell
31,151
-86
-0.3% -$11.2K 1.89% 4
2018
Q4 		$3.87M Sell
31,237
-3,920
-11% -$582K 1.84% 9
2018
Q3 		$5.91M Sell
35,157
-1,150
-3% -$198K 2.21% 5
2018
Q2 		$6.26M Sell
36,307
-60
-0.2% -$9.81K 2.45% 2
2018
Q1 		$5.49M Buy
36,367
+17,625
+94% +$2.59M 2.18% 4
2017
Q4 		$2.52M Sell
18,742
-95
-0.5% -$13.2K 0.94% 45
2017
Q3 		$2.75M Sell
18,837
-180
-0.9% -$27.2K 0.99% 41
2017
Q2 		$2.96M Sell
19,017
-155
-0.8% -$23.7K 1.11% 33
2017
Q1 		$2.78M Sell
19,172
-900
-4% -$117K 1.1% 38
2016
Q4 		$2.19M Buy
20,072
+1,210
+6% +$135K 0.91% 48
2016
Q3 		$2.29M Sell
18,862
-1,315
-7% -$177K 1.01% 46
2016
Q2 		$2.85M Buy
20,177
+205
+1% +$30.2K 1.28% 35
2016
Q1 		$2.61M Buy
19,972
+330
+2% +$41.1K 1.17% 40
2015
Q4 		$2.53M Buy
19,642
+778
+4% +$108K 1.19% 40
2015
Q3 		$2.5M Sell
18,864
-215
-1% -$37K 1.09% 43
2015
Q2 		$3.36M Buy
19,079
+864
+5% +$155K 1.31% 37
2015
Q1 		$3.15M Sell
18,215
-805
-4% -$138K 1.29% 35
2014
Q4 		$3.11M Sell
19,020
-262
-1% -$43.5K 1.23% 36
2014
Q3 		$3.1M Sell
19,282
-10,068
-34% -$1.55M 1.21% 36
2014
Q2 		$4.32M Sell
29,350
-535
-2% -$74.2K 1.75% 22
2014
Q1 		$4.14M Sell
29,885
-310
-1% -$46.7K 1.68% 22
2013
Q4 		$3.82M Sell
30,195
-420
-1% -$43.5K 1.54% 25
2013
Q3 		$2.82M Sell
30,615
-14,450
-32% -$1.17M 1.25% 34
2013
Q2 		$3.1M Buy
+45,065
New +$2.75M 1.55% 24

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Tealwood Asset Management's JAZZ Position: Q2 2020 in Review

Tealwood Asset Management sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2020, closing a stake of 18,273 shares — an estimated $1.82M sold.

Tealwood Asset Management first reported a position in JAZZ in Q2 2013 and held it in 28 quarters. The position peaked at $6.26M in Q2 2018. 384 funds tracked by Wall St. Rank hold JAZZ as of Q2 2020.

  • Tealwood Asset Management reported no remaining Jazz Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Tealwood Asset Management sold 18,273 Jazz Pharmaceuticals shares in Q2 2020, an estimated $1.82M.
  • Tealwood Asset Management first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 28 quarters.
  • Tealwood Asset Management's Jazz Pharmaceuticals position peaked at $6.26M in Q2 2018.
  • 384 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2020.

Based on Tealwood Asset Management's 13F filing for Q2 2020, filed 3 Aug 2020.